SCHEMBL29695639

SCHEMBL29695639

CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)C(C)C

nearest known ligand 0.65

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ TFPI P10646 6/20 0.62
▸ KDM1A O60341 3/20 0.62
▸ NPY2R P49146 7/20 0.60
▸ NPY4R P50391 7/20 0.60
▸ NPY5R Q15761 7/20 0.60
▸ NPY1R P25929 5/20 0.60
▸ MAOB P27338 1/20 0.59
▸ KDM5A P29375 1/20 0.59
▸ KDM1B Q8NB78 1/20 0.59
▸ EPHA2 P29317 1/20 0.58
▸ MAPK8 P45983 1/20 0.57
▸ MAPK9 P45984 1/20 0.57
▸ MAPK10 P53779 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29856103 0.95 TFPI (0.60) TFPIKDM1ANPY2RNPY4RNPY5R
SCHEMBL29903316 0.91 NPY2R (0.64) TFPIKDM1ANPY2RNPY4RNPY5R
SCHEMBL31182515 0.90 TFPI (0.68) TFPIKDM1ANPY2RNPY4RNPY5R
SCHEMBL30924728 0.90 EPHA2 (0.65) TFPIKDM1ANPY2RNPY4RNPY5R
SCHEMBL31182494 0.89 NPY2R (0.69) TFPIKDM1ANPY2RNPY4RNPY5R
SCHEMBL30578762 0.89 NTSR2 (0.60) KDM1ANPY2RNPY4RNPY5RNPY1R
SCHEMBL29356641 0.88 KDM1A (0.65) TFPIKDM1ANPY2RNPY4RNPY5R
SCHEMBL30176462 0.88 NPY2R (0.68) TFPIKDM1ANPY2RNPY4RNPY5R
SCHEMBL30567732 0.88 TFPI (0.64) TFPIKDM1ANPY2RNPY4RNPY5R
SCHEMBL30335912 0.88 NPY2R (0.60) TFPIKDM1ANPY2RNPY4RNPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4267193-A1 IMPROVED CD30 TARGETING ANTIBODY DRUG CONJUGATES AND USES THEREOF Ludwig-Maximilians-Universität München (DE) 2023-11-01 — — EP disclosed
WO-2022136555-A1 IMPROVED CD30 TARGETING ANTIBODY DRUG CONJUGATES AND USES THEREOF LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN (DE) 2022-06-30 — — WO disclosed
Send feedback